Axcella Health Inc. Profile Avatar - Palmy Investing

Axcella Health Inc.

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is …

Biotechnology
US, Cambridge [HQ]
AXLA/Leadership and Strategy

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of AXLA's Analysis
CIK: 1633070 CUSIP: 05454B105 ISIN: US05454B2043 LEI: - UEI: -
Secondary Listings
AXLA has no secondary listings inside our databases.